A randomized phase III study of carfilzomib vs low-dose corticosteroids with optional cyclophosphamide in relapsed and refractory multiple myeloma (FOCUS)
Hájek, R, Masszi, T, Petrucci, M T, Palumbo, A, Rosiñol, L, Nagler, A, Yong, K L, Oriol, A, Minarik, J, Pour, L, Dimopoulos, M A, Maisnar, V, Rossi, D, Kasparu, H, Van Droogenbroeck, J, Yehuda, D B, Hardan, I, Jenner, M, Calbecka, M, Dávid, M, de la Rubia, J, Drach, J, Gasztonyi, Z, Górnik, S, Leleu, X, Munder, M, Offidani, M, Zojer, N, Rajangam, K, Chang, Y-L, San-Miguel, J F, Ludwig, H
Published in Leukemia (01.01.2017)
Published in Leukemia (01.01.2017)
Get full text
Journal Article
Immunoglobulin heavy/light chain ratios improve paraprotein detection and monitoring, identify residual disease and correlate with survival in multiple myeloma patients
Ludwig, H, Milosavljevic, D, Zojer, N, Faint, J M, Bradwell, A R, Hübl, W, Harding, S J
Published in Leukemia (01.01.2013)
Published in Leukemia (01.01.2013)
Get full text
Journal Article
P873: CARFILZOMIB RESISTANCE IS ASSOCIATED WITH SIGNIFICANT DEREGULATION OF THE BH3 FAMILY PROTEINS
Schneller, A., Bolomsky, A., Zojer, N., Schreder, M., Ludwig, H.
Published in HemaSphere (23.06.2022)
Published in HemaSphere (23.06.2022)
Get full text
Journal Article
Efficacy of the combination of bortezomib and dexamethasone in systemic AL amyloidosis
Lamm, W, Willenbacher, W, Lang, A, Zojer, N, Müldür, E, Ludwig, H, Schauer-Stalzer, B, Zielinski, C. C, Drach, J
Published in Annals of hematology (01.02.2011)
Published in Annals of hematology (01.02.2011)
Get full text
Journal Article
Exome sequencing in tracking clonal evolution in multiple myeloma following therapy
Weston-Bell, N, Gibson, J, John, M, Ennis, S, Pfeifer, S, Cezard, T, Ludwig, H, Collins, A, Zojer, N, Sahota, S S
Published in Leukemia (01.05.2013)
Published in Leukemia (01.05.2013)
Get full text
Journal Article
Bortezomib in relapsed multiple myeloma: response rates and duration of response are independent of a chromosome 13q-deletion
SAGASTER, V, LUDWIG, H, KAUFMANN, H, ODELGA, V, ZOJER, N, ACKERMANN, J, KÜENBURG, E, WIESER, R, ZIELINSKI, C, DRACH, J
Published in Leukemia (01.01.2007)
Published in Leukemia (01.01.2007)
Get full text
Journal Article
Lenalidomide and dexamethasone for acute light chain-induced renal failure: a phase II study
Ludwig, Heinz, Rauch, Elisabeth, Kuehr, Thomas, Adam, Zdeněk, Weißmann, Adalbert, Kasparu, Hedwig, Autzinger, Eva-Maria, Heintel, Daniel, Greil, Richard, Poenisch, Wolfram, Müldür, Ercan, Zojer, Niklas
Published in Haematologica (Roma) (01.03.2015)
Published in Haematologica (Roma) (01.03.2015)
Get full text
Journal Article
P864: CTPS1 IS A NOVEL THERAPEUTIC TARGET IN MYELOMA ‐ SELECTIVE SMALL MOLECULE INHIBITION DELIVERS SINGLE AGENT ACTIVITY AND SYNERGISES WITH ATR INHIBITION
Pfeiffer, C., Beer, P., Asnagli, H., Bolomsky, A., Grandits, A., Schneller, A., Huber, J., Zojer, N., Schreder, M., Parker, A., Ludwig, H.
Published in HemaSphere (23.06.2022)
Published in HemaSphere (23.06.2022)
Get full text
Journal Article
The chemokine CXCL9 (MIG) is an independent predictor of overall survival in newly diagnosed multiple myeloma
Bolomsky, A, Schreder, M, Zojer, N, Ludwig, H
Published in Clinical lymphoma, myeloma and leukemia (01.09.2015)
Published in Clinical lymphoma, myeloma and leukemia (01.09.2015)
Get full text
Journal Article
My personal highlights of ESMO 2016
Dediu, M., Gerger, A., Zojer, N., Bartsch, R.
Published in Memo - Magazine of European medical oncology (2017)
Published in Memo - Magazine of European medical oncology (2017)
Get full text
Journal Article
S179: RANDOMIZED COMPARISON BETWEEN KRD AND KTD INDUCTION, FOLLOWED BY K MAINTENANCE OR OBSERVATION IN TRANSPLANT NON‐ELIGIBLE PATIENTS WITH NDMM (AGMT‐MM02 TRIAL)
Ludwig, H., Melchardt, T., Sormann, S., Zojer, N., Andel, J., Hartmann, B., Tinchon, C., Gunsilius, E., Podar, K., Egle, A., Willenbacher, W., Wöll, E., Schreder, M., Ruckser, R., Bozic, B, Krauth, M.‐T., Petzer, A., Schmitt, C, Machherndl‐Spandl, S., Agis, H., Fillitz, M., Pönisch, W., Knop, S., Paiva, B., Greil, R.
Published in HemaSphere (01.06.2022)
Published in HemaSphere (01.06.2022)
Get full text
Journal Article
Recent therapeutic advances in hematological malignancies: dealing with treatment-related complications
Get full text
Journal Article
Conference Proceeding
Immunoglobulin heavy/light chain ratios improve paraprotein detection and monitoring, identify residual disease and correlate with survival in multiple myeloma patients
Ludwig, H, Milosavljevic, D, Zojer, N, Faint, J.M, Bradwell, A.R, Hubl, W, Harding, S.J
Published in Leukemia (01.04.2013)
Published in Leukemia (01.04.2013)
Get full text
Journal Article
Heavy Chain/Light Chain Immunoassays for Monitoring Oligosecretory Multiple Myeloma Patients
Berlanga, O, Zojer, N, Milosavljevic, D, Hübl, W, Harding, S, Ludwig, H
Published in Clinical lymphoma, myeloma and leukemia (01.09.2015)
Published in Clinical lymphoma, myeloma and leukemia (01.09.2015)
Get full text
Journal Article
Heavy/Light Chain assays identify monoclonal intact immunoglobulin in ‘Light Chain only’ patients
Ludwig, H, Zojer, N, Milosavljevic, D, Hübl, W, Berlanga, O, Harding, S
Published in Clinical lymphoma, myeloma and leukemia (01.09.2015)
Published in Clinical lymphoma, myeloma and leukemia (01.09.2015)
Get full text
Journal Article
DNA vaccines to target the cancer testis antigen PASD1 in human multiple myeloma
Joseph-Pietras, D, Gao, Y, Zojer, N, Ait-Tahar, K, Banham, A H, Pulford, K, Rice, J, Savelyeva, N, Sahota, S S
Published in Leukemia (01.11.2010)
Published in Leukemia (01.11.2010)
Get full text
Journal Article